Clinical Trial

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Name: Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD — clinical trial record (NCT06997965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MIRIAD

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 participants with stricturing CD.

Protocol Amendment History 1 change

notable Trial sites expanded: 2 -> 5 locations 2026-07-17

Trial Details

NCT Number	NCT06997965
Lead Sponsor	Alimentiv Inc.
Conditions	Crohn Disease
Enrollment	60 participants
Start Date	2026-04-20
Primary Completion	2027-09-01 (estimated)
Study Completion	2028-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-16